Individualized treatment in stage IVC nasopharyngeal carcinoma

This publication has 72 references indexed in Scilit:

• Expression of ERCC1 predicts clinical outcome in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy
  Oral Oncology, 2012
• The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement
  Oral Oncology, 2012
• Current Management of Nasopharyngeal Cancer
  Seminars in Radiation Oncology, 2012
• Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literature
  Experimental and Therapeutic Medicine, 2012
• Can the Analysis of ERCC1 Expression Contribute to Individualized Therapy in Nasopharyngeal Carcinoma?
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
• High expression of excision repair cross-complementation group1 protein predicts poor outcome in patients with nasopharyngeal cancer
  Oral Oncology, 2010
• Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma
  Clinical Cancer Research, 2010
• Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
• Lung metastasis alone in nasopharyngeal carcinoma: A relatively favorable prognostic group
  Cancer, 2004
• Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002